Pathophysiology of Diabetic Dyslipidemia
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Accumulating clinical evidence has suggested serum triglyceride (TG) is a leading predictor of atherosclerotic cardiovascular disease, comparable to low-density lipoprotein (LDL)-cholesterol (C) in populations with type 2 diabetes, which exceeds the predictive power of hemoglobinA1c. Atherogenic dyslipidemia in diabetes consists of elevated serum concentrations of TG-rich lipoproteins (TRLs), a high prevalence of small dense low-density lipoprotein (LDL), and low concentrations of cholesterol-rich high-density lipoprotein (HDL)2-C. A central lipoprotein abnormality is an increase in large TG-rich very-low-density lipoprotein (VLDL)1, and other lipoprotein abnormalities are metabolically linked to increased TRLs. Insulin critically regulates serum VLDL concentrations by suppressing hepatic VLDL production and stimulating VLDL removal by activation of lipoprotein lipase. It is still debated whether hyperinsulinemia compensatory for insulin resistance is causally associated with the overproduction of VLDL. This review introduces experimental and clinical observations revealing that insulin resistance, but not hyperinsulinemia stimulates hepatic VLDL production. LDL and HDL consist of heterogeneous particles with different size and density. Cholesterol-depleted small dense LDL and cholesterol-rich HDL2 subspecies are particularly affected by insulin resistance and can be named "Metabolic LDL and HDL," respectively. We established the direct assays for quantifying small dense LDL-C and small dense HDL(HDL3)-C, respectively. Subtracting HDL3-C from HDL-C gives HDL2-C. I will explain clinical relevance of measurements of LDL and HDL subspecies determined by our assays. Diabetic kidney disease (DKD) substantially worsens plasma lipid profile thereby potentiated atherogenic risk. Finally, I briefly overview pathophysiology of dyslipidemia associated with DKD, which has not been so much taken up by other review articles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the activation of PPARα reduces small dense LDL particles by (1) producing apo C-III-poor VLDL particles that interacts less well CETP and (2) increasing the formation of large buoyant LDL that has a high affinity to and are easily taken up by LDL receptor.”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Non-elevated LDL cholesterol values together with higher triglycerides and lower HDL-cholesterol are common in patients with abdominal obesity, T2D, and metabolic syndrome (61, 62); these individuals often still have elevated atherogenic lipoproteins such as non-HDL (63), small LDL particles (62, 64), and VLDL (62, 64).”
From Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial (2019) · cites this paper as [64]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Cholesterol accumulation in the brain, particularly in astrocytes, contributes to this pathological process.”
From Cholesterol-driven pathological astrocytic responses in diabetes-associated cognitive impairment through astrocytic SCAP accumulation and NF-κB–C3 signaling modulation (2025) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Effects of extended-release niacin with laropiprant in high-risk patients
The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Cited by
Items 401–500 of 552
Gangadaran, S., Bonomini, F., Favero, G., Rezzani, R., & Moghadasian, M. H. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio119
Nyrén, R. (2020) · DiVA at Umeå University (Umeå University)
Gaipov, A., Nogaibayeva, A., Turebekov, Z., Zharmukhanbet, L., Orazbayev, G., Malykh, D., Kim, N., Abbay, A., Tuganbekovа, S., Aljofan, M., et al. (2021) · Electronic Journal of General Medicine · doi:10.29333/ejgm/10861
“Dyslipidemia is a metabolic abnormality that results in a persistent increase in the concentration of cholesterol and triglycerides in the plasma, which could lead to a number of complications including arteriosclerosis that commonly occurs secondary to increased plasmatic concentration of LDL [17].”
BackgroundHadi, A., & AlAteeq, M. A. (2021) · Cureus · doi:10.7759/cureus.15504
“%) for Low HDL-C level, hypertriglyceridemia, hypercholesterolemia, and hyper-LDL-C, respectively [10].”
BackgroundInfluentialApplications in medicine: hypoglycemic peptides
Jahandideh, F., & Wu, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821389-6.00023-6
Effect of Remnant Lipoprotein Cholesterol and Nitric Oxide in Young Coronary Heart Disease Subjects
Jaishankar, T., Shivasekar, M., Vinodhini, V. M., & Veeraragavan, S. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.131522
Hu, M. (2021) · F1000Research · doi:10.12688/f1000research.55215.1
“It is well known that both LDL andHDLconsist of heterogeneous particles of different size and density.(15)ApoB100 is the primary protein in LDL andApoAI is the primary protein in HDL.”
BackgroundNew Agents for Treatment of Dyslipidemia
Simha, V. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch17
Doya, L. J., Hassan, N. T., Nasser, E., & Khayat, M. I. (2020) · doi:10.21203/rs.3.rs-41463/v1
“This can be explained by insulin de ciency in PGC patients, which reduces the number of available LDL-C receptors and thus increases their concentration [22].”
BackgroundSimanjuntak, S. K., Wande, I. N., & Wirawati, I. A. P. (2021) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v28i1.1744
Glucose induced ApoB100/ApoAI ratio changes in cultured HepG2 cells in vitro
Hu, M. (2022) · F1000Research · doi:10.12688/f1000research.55215.2
Ubaidillah, N. (2021) · Jurnal Pertahanan Media Informasi tentang Kajian dan Strategi Pertahanan yang Mengedepankan Identity Nasionalism dan Integrity · doi:10.33172/jp.v7i3.1481
Lipid Variability and Diabetes Mellitus
Lee, J., & Lee, S. (2022) · Journal of Korean Diabetes · doi:10.4093/jkd.2022.23.1.28 · Cited by 2
“당뇨병 환자에서 나타나는 특징적인 이상지질혈증의 형태는 고중성지방혈증, small dense (sd) LDL-C의 상승, HDL-C 의 저하로 고혈당과 밀접한 관련이 있다[3,4].”
Association of Dyslipidemia and Type-I Diabetes Mellitus Among Children Up to 16 Years of Age
Akhter, S., Khoso, Z. A., Rai, V. R., Laghari, T. M., Parveen, R., Mahar, S., & Ibrahim, M. N. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22162704
The Effect of Blood Sugar Fasting Levels on Diabetic Dyslipidemia
Yasmin, R., Ahmed, A., Javed, A., Asim, M., Shabbir, R., Mushtaq, S., & Irshad, F. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164360
de Azarias, L. C. B., de Macêdo, A. C., dos Santos, M., Menezes, R. C. P., Santos, I. V., & Ribeiro, A. T. R. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001565
Schueda, M. A., Cohen, M., Lima, M. N., & Hornburg, G. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001574
ESTIMATIVA DO SEXO E IDADE ATRAVÉS DE MEDIDAS ANGULARES EM MANDÍBULAS SECAS DE ADULTOS
Sampaio, L. L., Santos, N. M., Lacerda, N. M. L., Neto, P. M. L., de Aquino, R. L. B., Angelim, S. Y. P., Júnior, E. D. A., & Galvão, L. C. C. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001566
Effects of Metformin and N-Acetylcysteine on Dyslipidemia in Streptozotocin-Induced Diabetic Rats
Bajwa, N. S., Sadaqat, S., Khan, W. U., Mohsin, M., Memon, M., Aslam, M. W., & Masud, R. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2216596
TREINAMENTO FÍSICO EM PERÍODO PÓS-CIRURGICO DE HÉRNIA DE DISCO LOMBAR
Meira, M. G., & Claro, R. F. T. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001560
AUTOCUIDADO DE PACIENTES COM DIABETES MELLITUS TIPO 2 DE DIFÍCIL CONTROLE EM ÉPOCA DE PANDEMIA
Severino, S. M., Rezende, H. H. A., de Oliveira, D. S., Santos, R. D. F., & Benite‐Ribeiro, S. A. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001561
Schueda, M. A., Cohen, M., Lima, M. N., & Hornburg, G. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001576
ALTERAÇÕES ORAIS ASSOCIADAS A PACIENTES TABAGISTAS: REVISÃO DE LITERATURA
Machado, M. V., & Gomes, S. L. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001569
ESTIMATIVA DO SEXO E IDADE POR MEIO DE MENSURAÇÕES EM TÍBIAS E FÍBULAS SECAS DE ADULTOS
Arraes, W. P. C. G., Angelim, S. Y. P., Grangeiro, P. H. M., Ramos, L. V. D. A., Santos, N. M., Filho, J. C. C. N., Júnior, E. D. A., & Galvão, L. C. C. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001568
SOFRIMENTO PSÍQUICO EM ESTUDANTES PRÉ-VESTIBULANDOS
de Melo, C. M. I., Carvalho, O. D. C. S. E., Martins, R. M. B., Bomfim, F. N. G., de Mattos, R. M. P. R., & Pimentel, D. M. M. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001572
Amorim, C. D. S., & Amorim, C. D. S. (2022) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001563
Natour, N., Bakri, F., Al-Tell, M. A., & Shaheen, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1744714/v1
Sekundär verursachte Dyslipoproteinämien und Atheroskleroserisiko
Schwab, K. O., & Doerfer, J. (2022) · Springer eBooks · doi:10.1007/978-3-662-63320-5_4
Zhuravlyova, L. V., Sokolnikova, N. V., & Rogachova, T. (2022) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2022.01.089 · Cited by 1
The articular cartilage: biomechanics and damage in diabetes-induced Charcot neuroarthropathy
Pierre-Jerome, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99352-4.00025-5
Jheetay, S., Garg, R., Adhana, R., Kumar, J., & Muniyal, H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.10706
“[20,21] Greater levels of endogenous DHT are typically associated with a better cardiovascular profile, including lower triglyceride levels, higher HDL cholesterol, lower blood sugar and blood pressure, according to the cross-sectional research.”
BackgroundElhabashy, S. A., Elbarbary, N. S., Hassan, A. A., & Thabet, R. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2011231/v1
Primaquine activates Keratin 7 to treat diabetes and its complications
Wu, T., Li, C., Zhou, J., Han, L., Qiang, S., Hu, Z., Liu, J., Li, X., Zhao, W., & Chen, X. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01135-8
“In addition, elevated free fatty acids (FFA) stimulate the production of very low-density lipoprotein (VLDL) in the liver which works as an indispensable factor of dyslipidemia [9].”
BackgroundPoursamileh, N., & Babaei-Balderlou, F. (2022) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.52547/jrums.21.7.698
Diabetes mellitus and the impact on triglycerides
Grigore, I., Gurău, G., Gurau, T. V., Tutunaru, D., Țocu, G., Țovîrnac, A. N., Neagu, A., Goroftei, L., Ciobotaru, O. C., & Ciobotaru, O. R. (2022) · Technium BioChemMed · doi:10.47577/biochemmed.v4i1.8025
Hubungan NF-kB Pada Diabetes Dislipidemia : Literature Review
Yulia, N., Aryzki, S., & Ikhsan, M. R. (2022) · Journal Pharmaceutical Care and Sciences · doi:10.33859/jpcs.v3i1.233
Diabetic dyslipidemia: focus on pathogenesis and treatment
Zhuravlyova, L. V., Sokolnikova, N. V., & Rogachova, T. (2022) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2022.02.049 · Cited by 2
Polat, Ö., Harmankaya, Ö., & Hatipoğlu, S. S. (2022) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2022-89479
“Cinsiyet Kadın Erkek n (%) n (%) p değeri ++Glukoz Bozulmuş açlık glukozu 263 (39) 150 (47,0) 0,017* Normal 411 (61,0) 169 (53,0) ++LDL Yüksek 242 (35,9) 110 (34,5) 0,662 Normal 432 (64,1) 209 (65,5) ++Total kolesterol Yüksek 228 (33,8) 106 (33,2) 0,852 Normal 446 (66,2) 213 (66,8) ++Trigliserid Yüksek 158 (23,4) 102…”
Atakul, G., Demiral, M., & Gürer, G. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0437
Abuajwa, A. E. S., Novida, H., Soebroto, H., & Sembiring, Y. E. (2023) · Majalah Biomorfologi · doi:10.20473/mbiom.v33i1.2023.30-37
Hypertriglyceridemia-induced Acute Pancreatitis in Diabetic Population
Reynaldo, G., Naomi, P., & Shalim, C. P. (2023) · International Journal of Medical and Biomedical Studies · doi:10.32553/ijmbs.v7i1.2659
The Effect of Edamame milk on Triglyceride Levels in Diabetes Wistar Rats
Ajeng, D., Ardiaria, M., Kurniawati, D. M., & Ayustaningwarno, F. (2022) · Sports Medicine Curiosity Journal · doi:10.15294/smcj.v1i2.61645
The hyperglycemic and dyslipidemic effects of L-arginine in streptozotocin-induced diabetic rats
Bajwa, N. S., Khan, M. W., Ishaq, N., Haider, Q. U. A., Yaseen, S., & Zafar, A. (2023) · Journal of Fatima Jinnah Medical University · doi:10.37018/nsbm.0901
(2023) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.2023.00978
Gluba-Brzózka, A., Rysz-Górzyńska, M., & Rysz, J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_9
Assessment of Cardiovascular Risk Factors Among Sudanese Patients with Type 2 Diabetes
Abdelrahim, H. M., Madani, A. M., & El-Hadiyah, T. M. (2023) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v18i2.13605
“Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus and this is attributed to the fact that diabetes can cause a variety of disarrangement in oxidative/reduction in lipid metabolic and regulatory mechanisms that might be responsible for the accumulation of lipids particles [26…”
BackgroundSaha, T., Sarma, N., Dawn, S., Dhar, A., Chatterjee, N., Hadem, I. K. H., Hazra, A., Pal, A., Sahoo, S., Dutta, A. K., et al. (2023) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v61i07.2214
Wang, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3264751/v1
Targeting one-carbon metabolism by methyl donors for prevention of non-alcoholic fatty liver in rats
Doghaither, H. A. A. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21802
Glycemic Control Determinant of Diabetes Mellitus Patients
Sukawana, I. W., Sukarja, I. M., Ningtyas, L. A. W., Suntari, N. L. P. Y., & Juniari, N. M. (2023) · Nursing and Health Sciences Journal (NHSJ) · doi:10.53713/nhsj.v3i2.223 · Cited by 1
“LDL particles, which are small and dense, are highly atherogenic because they are easily oxidized and difficult to clean (Hirano, 2018).”
Stanetić, K., Knežević, M. R., Petrović, V., Savić, S., Prodanović, D. T., & Marković, B. (2023) · Биомедицинска истраживања · doi:10.59137/bii202301308s · Cited by 1
Щастный, А. Т., Осочук, А. С., Martsinkevich, A. F., & Стефанович, О. С. (2023) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2023.12.3.015
Long duration of diabetes is associated with inadequate glycemic control and lipid profile
Bharti, R. K. (2023) · Journal of Research in Applied and Basic Medical Sciences · doi:10.61186/rabms.9.4.210
The effect of waxy siger rice on lipid profile diabetic mice induced by alloxan
Inke, L. A., Subeki, S., Hidayati, S. A., Utomo, T. P., & Astuti, S. (2023) · AIP conference proceedings · doi:10.1063/5.0142379
New Player in an Old Field? Ecto-F 1 -ATPase in Antidiabetic Actions of HDL in Pancreatic β-Cells
Mineo, C., & Shaul, P. W. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320426
Choi, H., Choi, J., & Kim, J.-I. (2023) · Journal of Nutrition and Health · doi:10.4163/jnh.2023.56.6.629
Fiadjoe, H. K., & Koffuor, G. A. (2024) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v14i1.6369
“The main association between diabetes and the higher risk of atherosclerosis and cardiovascular diseases is reflected by these lipid alterations which are more atherogenic than general dyslipidemia 10-13 .”
BackgroundDyslipidemia and Nonalcoholic Fatty Liver Disease in Rheumatoid Arthritis Patients
Хіміон, Л. В., & Klymas, I. (2023) · Family medicine European practices · doi:10.30841/2786-720x.4.2023.297030 · Cited by 3
Choi, H., Jo, A.-J., Kim, H.-N., & Kim, J.-I. (2024) · Journal of Nutrition and Health · doi:10.4163/jnh.2024.57.1.16
Wulandari, I. S., & Sutanto, K. (2024) · World Nutrition Journal · doi:10.25220/wnj.v07.i2.0002
Li, J., Nie, Z., Ge, Z., Shi, L., Gao, B., & Yang, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20625109
Current molecular understanding of peripheral arterial disease
Adkar, S. S., & Leeper, N. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13593-4.00006-8
A Novel Ai Model that Predicts Elevated Triglycerides Through Liver Cse-Mri Fat MapsPreprint
Jiang, B., Situ, W., Hu, J., Chen, X., Wang, Y., Kuang, J., Xiao, X., Wu, X., Yang, H., & Deng, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4870169
Study of Adhesion Molecules in Diabetes Mellitus Type2 Iraqi Patients with Dyslipidemia
Alsaedy, A. M., & Al-Rubaei, Z. M. (2024) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.6622273
Homocysteine and Visfatin Upregulation for Type 2 Diabetes Etiology
Ahmed, S., Ali, A. A., Jameel, M. G., Hamoo, M. T., majeed, M. F., Saleh, D. S. M., & Khalaf, S. H. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.849539
“Hirano, 2018).”
Glycemic Control and Cardiometabolic Risk in Black Zimbabweans with Type 2 Diabetes Mellitus
Chiveto, D., Musarurwa, C., Mapira, H. T., Kaseke, F., Nyengerai, T., Kaseke, T., & Gori, E. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s473042 · Cited by 1
“37 Based on the FRS-BMI, the majority of the participants (68.9”
BackgroundInfluentialKaneva, A. M., Потолицына, Н. Н., & Bojko, E. R. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2426970
“Free fatty acid-induced VLDL-apoB particle secretion is not always associated with VLDL-TG secretion, suggesting that free fatty acids could stimulate increased secretion of apoB without affecting secretion of TG [26,27].”
Therapeutic Efficacy of Flavonoid Morin against Dyslipidemia and Renal Damage in Diabetic Rat
Shali, K. S., & Mini, S. (2024) · Journal of advanced health research & clinical medicine. · doi:10.4103/jhcr.jhcr_18_24
Mishra, P. B., Jaiswal, R. P., & Bhushan, B. (2024) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v5i12.1491
Abdul-Wahab, S., & Saeed, G. T. (2025) · Obat · doi:10.61132/obat.v3i1.969
Анатольевич, С. А., Meshkov, A. N., & Владиславович, Е. М. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6179
Aging and ischemic stroke: mechanisms, trends, and strategies for improved outcomes
Kokaia, Z., & Martínez-Curiel, R. (2025) · Ageing & Longevity · doi:10.47855/jal9020-2025-2-7 · Cited by 1
Анатольевич, С. А., Meshkov, A. N., & Владиславович, Е. М. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6240 · Cited by 1
Máximo, A. S., do Couto, R. O., & Domingueti, C. P. (2022) · Revista Brasileira de Plantas Medicinais · doi:10.70151/6zhsh535 · Cited by 2
Musa, S. I., Adeyemi, A. A., & Ajayi, A. M. (2025) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-025-00833-x · Cited by 1
“All the treatment groups decreased the atherogenic index, coronary risk index and HDL/LDL ratio significantly (P < 0.05) in comparison to the HFD/STZ only treated group.”
InfluentialIto, H., & Mori, T. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0277
Bouadid, I., Bouymajane, A., Vinci, R. L., Altemimi, A. B., Cacciola, F., & Eddouks, M. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2508828
“In terms of lipid metabolism, diabetes often causes dyslipidemia, which is associated with insulin dysfunction (Hirano 2018).”
To determine the correlation of Triglyceride levels with HbA1c values in type 2 Diabetic patients
Moogaambiga, S., Rangabashyam, S. R., Nisha, S., & Mishra, V. S. (2024) · Cuestiones de Fisioterapia · doi:10.48047/7ngndg02
Tsamoulis, D., Papapanou, M., Platis, D., Giannakas, T., Ktenopoulos, N., & Rallidis, L. S. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2522225
“The lipid profile of NDDM (low HDL-C, high TGRs) is in accordance with what has been described as ‘diabetic dyslipi-demia’ [32].”
Scopelliti, E. M., & Cheung, N. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-88835-9_5
Future prospects of marine resources in fighting oxidative stress, diabetes, and obesity
Magwaza, S. N., & Islam, M. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29843-1.00006-9
Research Progress on sdLDL-C and Type 2 Diabetes Combined with Hypertension Disease
付, 阳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1572150
Noro, F., Marotta, A., Costanzo, S., Izzi, B., Gialluisi, A., Curtis, A. D., Pepe, A., Grossi, S., Castelnuovo, A. F. D., Cerletti, C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13081906
“Insulin resistance is the main underlying condition of metabolic syndrome, since insulin has beneficial effects on blood pressure, metabolism of lipids, and cholesterol-binding lipoproteins [40,41].”
Lipid metabolism in type 1 diabetes initiation and progression to vascular disease
Borowsky, N. S., Michel, R., Hirani, K., & Vendrame, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00028-2
Chantivas, T., Vathesatogkit, P., Chittamma, A., Thongmung, N., Kroll, M. H., & Srisawasdi, P. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.111018
Dia-Tracker: a Multimodal Diabetes Assistance Device
Khan, S., Mostofa, M. G., Joye, A., Jui, J. B., Rahman, J. F., & Roy, A. D. (2025) · IEEE International Conference on Quantum Photonics, Artificial Intelligence & Networking (QPAIN) · doi:10.1109/qpain66474.2025.11172255
“Diabetic dyslipidemia (DD) manifests itself by increased triglycerides, lowered low-density lipoprotein (LDL) cholesterol, and decreased high-density lipoprotein (HDL) levels, thereby raising the likelihood of cardiovascular disease both before and after meals [4].”
Kounatidis, D. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00287-9
Radić, J., Vučković, M., Đogaš, H., Ødeverp, A., Grubić, M., & Radić, M. (2025) · Biomedicines · doi:10.3390/biomedicines13102418 · Cited by 1
“Insulin resistance and chronic hyperglycemia decrease High-Density Lipoprotein Cholesterol (HDL-C) and increase LDL-C levels in the blood [22,23].”
Dysbetalipoproteinaemia in genetically predisposed Ghanaians
Ateko, R. O., Marais, A. D., Blom, D. J., Adadey, S. M., Thomford, N. E., & Blackhurst, D. M. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02787-0
“Typically, individuals with type 2 diabetes mellitus (T2DM) and insulin resistance have elevated TG levels and a higher proportion of small LDL particles [36].”
Association between elevated lipoprotein(a) levels and cardiovascular risk
Abushmaies, A. K., & Sufyan, M. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20253757
Suárez-Diéguez, T., Nájera, M. O., Silva, M., Rodríguez, G. L., Ariza‐Ortega, J. A., García-Tejedor, A., & Nieto, J. A. (2025) · Nutrients · doi:10.3390/nu17233807 · Cited by 2
“…it must be considered that, derived from insulin resistance, a TG and VLDL synthesis promotion occurs in the liver, as well as CHO increments [38,39], and these may explain the trend of slight increments of TG, VLDL, and CHO serum levels in diabetic individuals compared with non-diabetics.”
Sun, M., Yan, S., Zhao, D., Wang, L., Feng, T., Yang, Y., Li, X., Hu, W., Yao, N., Cui, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19695836
Wu, T.-W., Chou, C.-L., Cheng, C.-F., Lu, S.-X., Wu, Y.-J., & Wang, L. (2023) · Figshare · doi:10.6084/m9.figshare.22626001
Pan, J., Yang, X., & Zhu, W. (2021) · Figshare · doi:10.6084/m9.figshare.14684406
Colantoni, A., Bucci, T., Cocomello, N., Angelico, F., Ettorre, E., Pastori, D., Lip, G. Y. H., Ben, M. D., & Baratta, F. (2024) · Figshare · doi:10.6084/m9.figshare.25865096
Serum Lipid Profile and HbA1c Status in Different Group of Diabetic Patients
Parvin, R., Rahman, M., & Parvin, R. (2024) · TAJ Journal of Teachers Association · doi:10.70818/taj.v037i02.0454
Zhang, Q., Zhou, Y., Fu, L., Xing, Z., Deng, X., Yi, S., & Tai, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70374 · Cited by 2
“51 Conversely, reduced HDL-C impairs reverse cholesterol transport and weakens HDL's antioxidative and anti-inflammatory functions.”
Metadata
- Authors
- Hirano, T.
- Affiliations
- SHOWA Medical University (JP)
- Corresponding author
- Hirano, Tsutomu
- ORCID
- Hirano, Tsutomu
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2018-09-01
- Volume
- 25
- Issue
- 9
- Pages
- 771-782
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- PMC
- PMC6143775
- OpenAlex
- W2820707192
- Cited by
- 552
- References
- 102
- Citations by year
- 2026: 65 · 2025: 90 · 2024: 81 · 2023: 86 · 2022: 88 · 2021: 70 · 2020: 46 · 2019: 21 · 2018: 4
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Atherosclerosis and Thrombosis (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- diabetic dyslipidemia, type 2 diabetes, triglyceride-rich lipoproteins, VLDL, small dense LDL, HDL2, HDL3 cholesterol, insulin resistance, hyperinsulinemia, lipoprotein lipase, atherosclerotic cardiovascular disease, diabetic nephropathy, plasma lipid profile
- MeSH terms
- Pioglitazone, Animals, Cholesterol, Chylomicrons, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Fatty Acids, Nonesterified, Glycated Hemoglobin, Humans, Insulin, Insulin Resistance, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Lipoproteins, VLDL, Liver, Risk, Triglycerides, Cholesterol, VLDL, Dyslipidemias, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.